Choose 1 of your opponent's Pokémon. This attack does 30 damage to that Pokémon. This attack's damage isn't affected by Weakness, Resistance, Poké-Powers, Poké-Bodies, or any other effects on that Pokémon.
Flip a coin. If heads, this attack does 40 damage plus 10 more damage.
Legends Awakened was released in 2008. It belongs to the Diamond & Pearl series.
With 146 listed cards, this is a mid-size set by modern TCG standards. As of 2026, the set is 18 years old and fits a legacy-era profile.
In the Legends Awakened checklist, Persian occupies position #68 as a Uncommon card.
Persian is a Legends Awakened card from the 2008 release window. Card flavor text reads: "A very haughty Pokémon.
Among fans, the size of the jewel in its forehead is a topic of much talk." Its card type is Pokémon. The rarity label is Uncommon.
Printed HP is 80. Energy typing is Colorless.
This gives collectors a clear identity footprint for the print. This card evolves from Meowth.
Latest market snapshots place Persian in Legends Awakened at roughly $0.54. The 7-day delta remains near neutral at 0.0%.
Current pricing is broadly aligned with its 30-day average ($0.54). In the past 90 days, observed prices ranged from $0.48 to $0.54 (11% spread), a low-volatility profile.
This version is categorized as Uncommon.
Other Persian printings create a useful comparison set for Persian. This comparison sample includes 6 alternatives across 5 sets.
In this sample, pricing ranges between $0.09 and $43.51 (48244% total span). Relative to the alternative average ($7.38), this card is -93%.
Notable alternatives include Persian #62 (Ancient Origins) at $0.18, Persian #89 (Steam Siege) at $0.21, Persian #200 (Fusion Strike) at $0.15, and Persian #49 (Shrouded Fable) at $0.09.
Market structure summary: We observe a 0.0% shift this week, which points toward price consolidation rather than immediate volatility. With a 11% 90-day spread ($0.48-$0.54), this card currently tracks as low-volatility.
Relative to the 30-day baseline ($0.54), pricing is near equilibrium. Graded comparison currently centers on PSA 9 near $54.99, representing +10083% over raw value.
